Pure Global

HCV Ab FIA Test - India CDSCO Medical Device Registration

HCV Ab FIA Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000021_152a15adbbd28760f69404c573739b0a_384c2065e8a5095af68714dd28cb5da3. This device is marketed under the brand name PathoCatchTM. The license holder is Mylab Discovery S0lutions Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
HCV Ab FIA Test
UID: MFG/IVD/2020/000021_152a15adbbd28760f69404c573739b0a_384c2065e8a5095af68714dd28cb5da3

Brand Name

PathoCatchTM

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

HCV Ab FIA Test is a fluorescent immunoassay for the detection of Hepatitis C virus (PathoCatchTM) antibodies in human serum, plasma and whole blood. This test kit is for in vitro diagnostic professional use and is intended as an aid to the early detection of the Hepatitis C virus, and provides only an initial screening test result. More specific alternative diagnosis methods should be performed to obtain confirmation of the Hepatitis C virus (PathoCatchTM)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing